Response to pralatrexate in patients with cutaneous T-cell lymphoma. Skin photographs documenting disease in a patient with mycocis fungoides (MF) stage IIB (A) before the start of treatment with pralatrexate and (B) after 4 cycles of treatment with pralatrexate.